These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34358520)

  • 1. Mandatory Nodal Evaluation During Resection of Clinical T1a Non-Small Cell Lung Cancers.
    Dezube AR; Mazzola E; Deeb A; Wiener DC; Marshall MB; Rochefort MW; Jaklitsch MT
    Ann Thorac Surg; 2022 May; 113(5):1583-1590. PubMed ID: 34358520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer.
    Robinson EM; Ilonen IK; Tan KS; Plodkowski AJ; Bott M; Bains MS; Adusumilli PS; Park BJ; Rusch VW; Jones DR; Huang J
    Ann Thorac Surg; 2020 Jan; 109(1):270-276. PubMed ID: 31479639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection.
    Oda M; Watanabe Y; Shimizu J; Murakami S; Ohta Y; Sekido N; Watanabe S; Ishikawa N; Nonomura A
    Lung Cancer; 1998 Oct; 22(1):23-30. PubMed ID: 9869104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer.
    Graham AN; Chan KJ; Pastorino U; Goldstraw P
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):246-51. PubMed ID: 9918964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
    Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    Kneuertz PJ; Cheufou DH; D'Souza DM; Mardanzai K; Abdel-Rasoul M; Theegarten D; Moffatt-Bruce SD; Aigner C; Merritt RE
    J Thorac Cardiovasc Surg; 2019 Nov; 158(5):1457-1466.e2. PubMed ID: 31623811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    Clin Lung Cancer; 2021 Mar; 22(2):120-126.e3. PubMed ID: 33485802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does anatomical segmentectomy allow an adequate lymph node staging for cT1a non-small cell lung cancer?
    Mattioli S; Ruffato A; Puma F; Daddi N; Aramini B; D'ovidio F
    J Thorac Oncol; 2011 Sep; 6(9):1537-41. PubMed ID: 21642864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?
    Asamura H; Nakayama H; Kondo H; Tsuchiya R; Shimosato Y; Naruke T
    J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1125-34. PubMed ID: 8642812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
    Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
    Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it necessary to sample the contralateral nodal stations by EBUS-TBNA in patients with lung cancer and clinical N0 / N1 on PET-CT?
    Serra P; Centeno C; Sanz-Santos J; Torky M; Baeza S; Mendiluce L; Martínez-Barenys C; López de Castro P; Abad J; Rosell A; Andreo F
    Lung Cancer; 2020 Apr; 142():9-12. PubMed ID: 32062200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geometrical Measurement of Central Tumor Location in cT1N0M0 NSCLC Predicts N1 but Not N2 Upstaging.
    Sanz-Santos J; Martínez-Palau M; Jaen À; Rami-Porta R; Barreiro B; Call S; Obiols C; González JM; De Marcos JÁ; Ysamat M; Canales L; Serra M; Belda J
    Ann Thorac Surg; 2021 Apr; 111(4):1190-1197. PubMed ID: 32853568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
    Cerfolio RJ; Bryant AS; Minnich DJ
    Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.